Treatment with entecavir or tenofovir disoproxil fumarate in mono-infected patients with chronic hepatitis B in a real-world setting: the MENTE study.

Trial Profile

Treatment with entecavir or tenofovir disoproxil fumarate in mono-infected patients with chronic hepatitis B in a real-world setting: the MENTE study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Aug 2015

At a glance

  • Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
  • Indications Hepatitis B
  • Focus Adverse reactions
  • Acronyms MENTE
  • Most Recent Events

    • 31 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top